Safety and Efficacy of the Combination of Furosemide 40 mg + Amiloride Hydrochloride 10 mg in the Reduction of Edema of Cardiac Origin in Patients With Congestive Heart Failure Functional Class II (NYHA).
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Furosemide/amiloride (Primary) ; Furosemide
- Indications Heart failure
- Focus Therapeutic Use
Most Recent Events
- 09 Oct 2019 Biomarkers information updated
- 26 Jun 2013 Planned End Date changed from 1 May 2011 to 1 Feb 2013 as reported by ClinicalTrials.gov.
- 26 Jun 2013 Status changed from not yet recruiting to suspended as reported by ClinicalTrials.gov.